Most low testosterone is obesity-related, age-related, or idiopathic secondary hypogonadism. Pituitary tumors are rare but clinically significant — and missing a pituitary adenoma because testosterone was treated without investigating the cause is a medical error worth avoiding.
When Pituitary Imaging Is Warranted
Indications for Pituitary MRI
- Very low testosterone (<150 ng/dL) with low LH/FSH — suggests significant pituitary suppression beyond typical functional causes
- Low LH/FSH with other pituitary hormone deficiencies: If thyroid (low free T4 with low/normal TSH) or cortisol (low morning cortisol) are also low, multiple pituitary axes are failing — this raises the probability of a pituitary lesion
- Elevated prolactin: Prolactinoma (prolactin-secreting pituitary adenoma) is one of the most common pituitary tumors and frequently presents with low testosterone. Elevated prolactin (>25 ng/mL in men) should prompt MRI.
- Visual field changes: Bitemporal hemianopia (loss of peripheral vision on both sides) suggests a pituitary macroadenoma compressing the optic chiasm
- Headaches + low T: New, persistent headaches combined with low testosterone warrant investigation
- Young men (<40) with no obvious cause: Young men without obesity, medication, or other obvious causes of secondary hypogonadism deserve a more thorough workup
What the MRI Shows
Pituitary MRI with gadolinium contrast can identify: pituitary adenomas (most commonly prolactinomas, non-functioning adenomas, or GH-secreting tumors), Rathke's cleft cysts, empty sella, and other structural abnormalities. Most findings are incidental microadenomas (<10mm) that don't require treatment — but knowing they're there changes monitoring.
What Happens If Something Is Found
Prolactinomas are treated with cabergoline (dopamine agonist) — which often normalizes prolactin AND testosterone without needing TRT. Non-functioning microadenomas are typically monitored with serial MRI. Macroadenomas may require surgery (transsphenoidal resection) or medical management depending on type and size.
The Bottom Line
Screen Before You Supplement
Pituitary tumors are uncommon but treatable — and they present as low testosterone. Very low T with low LH, elevated prolactin, or multiple pituitary hormone deficiencies should prompt MRI before starting TRT. Finding a prolactinoma early means treating the cause (cabergoline) rather than supplementing around it (TRT) while the tumor grows. A complete baseline panel that includes prolactin is the first screening step.